You just read:

Neurocrine Announces INGREZZA™ Long-Term Safety and Efficacy Data to be Presented at the 2017 American Academy of Neurology Annual Meeting

News provided by

Neurocrine Biosciences, Inc.

Apr 21, 2017, 06:00 ET